Oncology - Hepatobiliary/Pancreas News & Articles

1 HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer Oncogene, May 23, 2012

2 Short-Term Outcomes of Ablation Therapy for Hepatic Tumors: Evidence from the 2006–2009 Nationwide Inpatient Sample Annals of Surgical Oncology, May 23, 2012

3 Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study European Journal of Radiology, May 23, 2012

4 Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma American Journal of Clinical Oncology, May 22, 2012

5 Meat and fish consumption and risk of pancreatic cancer--results from the European prospective investigation into cancer and nutrition International Journal of Cancer, May 22, 2012

6 Real-world Impact of Availability of Adjuvant Therapy on Outcomes in Patients With Resected Pancreatic Adenocarcinoma American Journal of Clinical Oncology, May 22, 2012

7 Cytopathologic evaluation of the in situ margin in patients undergoing hepatectomy Cancer Cytopathology, May 22, 2012

8 Oxidative dna damage correlates with cell immortalization and mir-92 expression in hepatocelllular carcinoma Full Text BMC Cancer, May 22, 2012

9 High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: differentiation between benignity and malignancy Journal of Gastroenterology, May 22, 2012    Clinical Article

10 Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes World Journal of Surgical Oncology, May 22, 2012

11 Hepatic artery injection of 131I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study European Journal of Nuclear Medicine & Molecular Imaging, May 22, 2012

12 The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection Annals of Surgical Oncology, May 22, 2012

13 Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma British Journal of Cancer, May 21, 2012

14 Risk of liver cancer among US male veterans with cirrhosis, 1969-1996 British Journal of Cancer, May 21, 2012

15 Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators Cancer, May 21, 2012

16 Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers Cancer, May 21, 2012

17 Identification of Serum Biomarker Signatures Associated with Pancreatic Cancer Cancer Research, May 21, 2012

18 Hepatocyte–Stellate Cell Cross-Talk in the Liver Engenders a Permissive Inflammatory Microenvironment That Drives Progression in Hepatocellular Carcinoma Cancer Research, May 21, 2012

19 Enhancement pattern analysis of hypervascular hepatocellular carcinoma on dynamic MR imaging with histopathological correlation: Validity of portal phase imaging for predicting tumor grade European Journal of Radiology, May 21, 2012    Clinical Article

20 VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials The Lancet Oncology - Online First, May 18, 2012

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

2 Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer Cancer, April 20, 2012

3 Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent Cancer, April 18, 2012

4 Improved Chemotherapy for Hepatocellular Carcinoma Anticancer Research, April 11, 2012

5 Pancreatoduodenectomy Following Neoadjuvant Chemoradiation Therapy in Uncinate Process Pancreatic Cancer Pancreas, April 2, 2012

6 Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma Journal of Gastrointestinal Surgery, April 9, 2012

7 Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Annals of Oncology, March 21, 2012

8 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

9 An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer Pancreas, March 27, 2012

10 Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer Clinical Cancer Research, March 26, 2012

11 Stool DNA testing for the detection of pancreatic cancer Cancer, April 17, 2012

12 Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy Journal of Gastrointestinal Surgery, April 2, 2012

13 Study of AP Endonuclease (APEX1/REF1), a DNA Repair Enzyme, in Gallbladder Carcinoma Anticancer Research, April 10, 2012

14 Metformin and Hepatic Carcinogenesis Cancer Prevention Research, April 12, 2012

15 Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma Journal of Gastrointestinal Surgery, April 10, 2012

16 Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial The Oncologist, April 3, 2012    Free full text

17 Adjuvant Chemoradiotherapy After Curative Resection for Extrahepatic Bile Duct Cancer: A Long-term Single Center Experience American Journal of Clinical Oncology, March 22, 2012

18 Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene Cancer, April 26, 2012

19 Gene Deletions and Amplifications in Human Hepatocellular Carcinomas: Correlation with Hepatocyte Growth Regulation The American Journal of Pathology, March 30, 2012

20 Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer International Journal of Cancer, April 23, 2012